Key Research Properties: Small molecule NNMT (nicotinamide N-methyltransferase) inhibitor Modulates NAD+ metabolism and methylation capacity Studied in context of energy expenditure and metabolic regulation NNMT is upregulated in obesity
Phase Weeks 3+ (standard) Daily dose 100 mg once daily Notes The most common research community target dose
Angiogenesis: Building New Blood Supply One of the most important things BPC-157 does is stimulate angiogenesis, which is the formation of new blood vessels
If you need multiple samples, use a new sterile syringe for each withdrawal
Wait 72 hours before using RapidBac if a chemical is applied to the pond
Read review Dihexa for Migraine & Chronic Migraine The May 2024 NICE TA973 atogepant (Aquipta, AbbVie) approval, the rimegepant / erenumab / galcanezumab / fremanezumab / eptinezumab CGRP pathway, 2025 chronic-migraine hippocampal atrophy & accelerated brain ageing research, the Tanure BDNF-elevated-in-attack paradox, NICE NG150, and the ~10 million UK migraine population